Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Self-assembled mRNA vaccines
Jeonghwan Kim, Yulia Eygeris, Mohit Gupta, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 83-112
Open Access | Times Cited: 364

Showing 1-25 of 364 citing articles:

Lipid nanoparticles for mRNA delivery
Xucheng Hou, Tal Zaks, Róbert Langer, et al.
Nature Reviews Materials (2021) Vol. 6, Iss. 12, pp. 1078-1094
Open Access | Times Cited: 2088
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
Linde Schoenmaker, Dominik Witzigmann, Jayesh A. Kulkarni, et al.
International Journal of Pharmaceutics (2021) Vol. 601, pp. 120586-120586
Open Access | Times Cited: 996
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Namit Chaudhary, Drew Weissman, Kathryn A. Whitehead
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 11, pp. 817-838
Open Access | Times Cited: 939
Chemistry of Lipid Nanoparticles for RNA Delivery
Yulia Eygeris, Mohit Gupta, Jeonghwan Kim, et al.
Accounts of Chemical Research (2021) Vol. 55, Iss. 1, pp. 2-12
Closed Access | Times Cited: 453
Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 392
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 384
Overcoming barriers by local drug delivery with liposomes
Sophia G. Antimisiaris, Antonia Marazioti, Maria Kannavou, et al.
Advanced Drug Delivery Reviews (2021) Vol. 174, pp. 53-86
Closed Access | Times Cited: 245
Dynamic and reconfigurable materials from reversible network interactions
Matthew J. Webber, Mark W. Tibbitt
Nature Reviews Materials (2022) Vol. 7, Iss. 7, pp. 541-556
Closed Access | Times Cited: 206
mRNA-based cancer therapeutics
Chuang LIU, Qiangqiang Shi, Xiangang Huang, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 8, pp. 526-543
Closed Access | Times Cited: 201
COVID-19 mRNA vaccines: Platforms and current developments
Gábor Szabó, Azita J. Mahiny, Irena Vlatkovic
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1850-1868
Open Access | Times Cited: 194
A Comprehensive Review of mRNA Vaccines
Vrinda Gote, Pradeep Kumar Bolla, Nagavendra Kommineni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2700-2700
Open Access | Times Cited: 180
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy
Yan Zong, Yi Lin, Tuo Wei, et al.
Advanced Materials (2023) Vol. 35, Iss. 51
Closed Access | Times Cited: 161
Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development
Meenu Mehta, Thuỳ Anh Bùi, Xinpu Yang, et al.
ACS Materials Au (2023) Vol. 3, Iss. 6, pp. 600-619
Open Access | Times Cited: 135
Lipid nanoparticles in the development of mRNA vaccines for COVID-19
Barnabas Wilson, K. Geetha
Journal of Drug Delivery Science and Technology (2022) Vol. 74, pp. 103553-103553
Open Access | Times Cited: 132
Nanomaterials Synthesis through Microfluidic Methods: An Updated Overview
Adelina-Gabriela Niculescu, Cristina Chircov, Alexandra Cătălina Bîrcă, et al.
Nanomaterials (2021) Vol. 11, Iss. 4, pp. 864-864
Open Access | Times Cited: 124
Nanoparticle-Based Delivery Systems for Vaccines
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 124
Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation
Jeonghwan Kim, Antony Jozić, Yuxin Lin, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 14792-14806
Open Access | Times Cited: 123
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Monika Kumari, Ruei‐Min Lu, Mu‐Chun Li, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 111
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Han Na Jung, Seok‐Yong Lee, Somin Lee, et al.
Theranostics (2022) Vol. 12, Iss. 17, pp. 7509-7531
Open Access | Times Cited: 108
mRNA nanomedicine: Design and recent applications
Luke J. Kubiatowicz, Animesh Mohapatra, Nishta Krishnan, et al.
Exploration (2022) Vol. 2, Iss. 6
Open Access | Times Cited: 83
Quality by Design for enabling RNA platform production processes
Simon Daniel, Zoltán Kis, Cleo Kontoravdi, et al.
Trends in biotechnology (2022) Vol. 40, Iss. 10, pp. 1213-1228
Open Access | Times Cited: 73
PEGylated therapeutics in the clinic
Yongsheng Gao, Maithili Joshi, Zongmin Zhao, et al.
Bioengineering & Translational Medicine (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 67
Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
K. Swetha, Niranjan G. Kotla, Lakshmi Tunki, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 658-658
Open Access | Times Cited: 58
mRNA vaccine in cancer therapy: Current advance and future outlook
Youhuai Li, Mina Wang, Xueqiang Peng, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 57
Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top